Osteoporosis during Continuous Androgen Deprivation: Influence of the Modality and Length of Treatment

Author： Morote J.   Martinez E.   Trilla E.   Esquena S.   Abascal J.M.   Encabo G.   Reventos J.  

Publisher： Elsevier

ISSN： 0302-2838

Source： European Urology, Vol.44, Iss.6, 2003-12, pp. : 661-665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Severe Symptomatic Osteoporosis in Patients on Androgen Deprivation Therapy for Prostatic Carcinoma

By Paterson C. R.   Mole P. A.  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 4, 2002-09 ,pp. : 314-316

Informa Healthcare

Access to resources Recommend Favorite

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

By Hedlund Per Olov   Johansson Robert   Damber Jan Erik   Hagerman Inger   Henriksson Peter   Iversen Peter   Klarskov Peter   Mogensen Peter   Rasmussen Finn   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 5, 2011-11 ,pp. : 346-353

Informa Healthcare

Access to resources Recommend Favorite

Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting

By Berge Viktor   Thompson Trevor   Blackman Donald  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 3, 2007-01 ,pp. : 198-203

Informa Healthcare

Access to resources Recommend Favorite

Electrovaporization as a treatment modality for transurethral resection of the prostate: influence of generator type

By van Swol C.F.P.   van Vliet R.J.   Verdaasdonk R.M.   Boon T.A.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 317-321

Elsevier

Access to resources Recommend Favorite

Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer – Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

By Hedlund Per Olov   Ala-Opas Martti   Brekkan Einar   Damber Jan Erik   Damber Lena   Hagerman Inger   Haukaas Svein   Henriksson Peter   Iversen Peter   Pousette Åke   Rasmussen Finn   Salo Jaakko   Vaage Sigmund   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 6, 2002-12 ,pp. : 405-413

Informa Healthcare

Access to resources Recommend Favorite